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ARTICLE
Cell-Type Heterogeneity in Adipose Tissue Is
Associated with Complex Traits and Reveals
Disease-Relevant Cell-Specific eQTLs
Craig A. Glastonbury,1,2,* Alexessander Couto Alves,1 Julia S. El-Sayed Moustafa,1 and Kerrin S. Small1,*
Adipose tissue is an important endocrine organ with a role in many cardiometabolic diseases. It is comprised of a heterogeneous collec-
tion of cell types that can differentially impact disease phenotypes. Cellular heterogeneity can also confound -omic analyses but is rarely
taken into account in analysis of solid-tissue transcriptomes. Here, we investigate cell-type heterogeneity in two population-level sub-
cutaneous adipose-tissue RNA-seq datasets (TwinsUK, n ¼ 766 and the Genotype-Tissue Expression project [GTEx], n ¼ 326) by esti-
mating the relative proportions of four distinct cell types (adipocytes, macrophages, CD4þ T cells, and micro-vascular endothelial cells).
We find significant cellular heterogeneity within and between the TwinsUK and GTEx adipose datasets. We find that adipose cell-type
composition is heritable and confirm the positive association between adipose-resident macrophage proportion and obesity (high BMI),
but we find a stronger BMI-independent association with dual-energy X-ray absorptiometry (DXA) derived body-fat distribution traits.
We benchmark the impact of adipose-tissue cell composition on a range of standard analyses, including phenotype-gene expression as-
sociation, co-expression networks, and cis-eQTL discovery. Our results indicate that it is critical to account for cell-type composition
when combining adipose transcriptome datasets in co-expression analysis and in differential expression analysis with obesity-related
traits.We applied gene expression by cell-type proportion interactionmodels (G3Cell) to identify 26 cell-type-specific expression quan-
titative trait loci (eQTLs) in 20 genes, including four autoimmune disease genome-wide association study (GWAS) loci. These results
identify cell-specific eQTLs and demonstrate the potential of in silico deconvolution of bulk tissue to identify cell-type-restricted regu-
latory variants.Introduction
Adipose tissue is the largest endocrine organ in the human
body and has a role in the development of insulin resis-
tance, cardiovascular disease, type 2 diabetes, and many
other cardiometabolic disorders. Adipose tissue is hetero-
geneous; it is comprised of an array of cell types including
adipocytes, pre-adipocytes, endothelial cells, and several
immune cell subtypes.1 Adipose tissue cellular composi-
tion changes in response to obesity, and it is thought
that this change, in particular the marked increase in im-
mune-cell infiltration, contributes to some of the negative
health consequences of obesity.2–4 It is therefore of interest
to understand the cellularity of adipose tissue, its vari-
ability in the population, and how this affects health and
disease.
As a result of the biomedical importance and relatively
easy physical accessibility of subcutaneous adipose tissue,
a large body of adipose transcriptomic datasets has been
generated from multiple studies, including several studies
with more than 200 participants.5–10 To our knowledge,
these studies have not assessed the cellular composition
of their samples, despite the fact that cellular heterogene-
ity is a well-established confounder in transcriptomic anal-
ysis of bulk tissues.11–13 Although extensive investigation
and methodological development has centered on compu-
tationally accounting for cell-type composition in whole
blood,13 very few studies have investigated the extent of1Department of Twin Research and Genetic Epidemiology, King’s College Lon
2Present address: BenevolentAI, London, UK
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 2019 The Author(s). This is an open access article under the CC BY licensecellular heterogeneity in other tissues and how it
impacts -omic-level analyses.14 Directly assessing cell-
type composition in adipose tissue is challenging; methods
such as flow sorting face technical difficulties, including
adipocyte rupturing and shared cell-type-specific surface
markers, as well as low throughput and high expense
when applied to hundreds of samples. Single-cell analysis
could overcome some of these considerations; however,
the complex logistics of population-level collection of adi-
pose biopsies and the expense of single-cell analysis mean
that there is considerable utility in in silico deconvolution
of -omic profiles generated from bulk adipose tissue.
Here, we utilize in silico deconvolution to estimate the
relative proportions of four distinct cell types (adipocytes,
macrophages, CD4þ T cells, and micro-vascular endothe-
lial cells [MVEC]) in bulk subcutaneous adipose-tissue
transcriptomes from two independent datasets: 766 indi-
viduals from TwinsUK and 326 post-mortem Genotype-
Tissue Expression project (GTEx) donors. We conduct
extensive simulations to investigate whether our methods
accurately identify the relevant cell types, the range of cell-
type detection possible, and robustness to varying levels of
noise and unknown cell content (contamination). We find
significant cellular heterogeneity within and between
these datasets. We recapitulate the well-known cellular
hallmark of obesity and find a positive association between
adipose-tissue macrophage abundance and body-mass
index (BMI), but we identify stronger relationships todon, London SE1 7EH, UK
.ac.uk (K.S.S.)
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dual-energy X-ray absorptiometry (DXA) derived body-fat
distribution traits. We assess the impact of adipose cellular
heterogeneity on standard -omic analyses, including
cis-eQTL discovery, co-expression networks, and differen-
tial gene-expression studies. Finally, we utilize cell-type
composition in interaction models to identify cell-type-
specific expression quantitative trait loci (eQTLs) from
bulk-tissue transcriptomes that are enriched for genome-
wide association study (GWAS) variants and cell-type-rele-
vant enhancers.Material and Methods
RNA-Seq Alignment and Gene Quantification
All (adipose tissue, primary cells, and iPSCs) reference data were
aligned, subjected to quality control (QC), and quantified with
the same pipeline to ensure comparability. Reads were aligned to
the hg19 reference genome with STAR version 2.4.0.1.15 All
aligned binary sequence alignment maps were then filtered to
isolate those containing reads with a mapping quality greater
than 10, and among those, only reads that were properly paired
and had two or fewer mismatches were kept. Samples were
excluded if they had fewer than 10 million reads mapping to
known genes or if the sequence data did not correspond to actual
genotype data as assessed with the ‘‘mbv’’ mode of QTLtools.16
GENCODE annotation v19 gene counts were calculated via featur-
eCounts17 and only genes that coded for proteins and did not have
retained intron transcripts. All gene counts were transformed into
trimmed mean of M-values (TMM), a unit shown to be well suited
for an across-cell-type study design and that also accounts for
library size differences.18,19 Although all protein-coding genes
were used for cell-type estimation (20,345 genes) because filtering
lowly expressed genes could bias cell-type estimates to highly
abundant cells in a given tissue biopsy, genes with at least 0.5
TMM expressed in 90% of samples within a dataset were retained
for transcription-wide association and eQTL analysis.
TwinsUK Dataset
Sub-umbilical, subcutaneous adipose-tissue punch biopsies were
collected from female twins from the TwinsUK cohort, as
described previously.5,6 RNA-seq data are available in EGA (EGA:
S00001000805). QC) of the TwinsUK genotypes has been
described previously.6,20 After QC, 766 TwinsUK samples were
available for analysis, of which 720 had available genotypes. The
TwinsUK adipose samples had a median age of 60 [38–84] andme-
dian BMI of 25 [16–47]. Cell-type proportions of TwinsUK samples
are listed in Table S1.
GTEx RNA-Seq Dataset
RNA-seq FASTQ data for all GTEx v. 6p subcutaneous adipose-tis-
sue samples were downloaded from the database of genotypes
and phenotypes (dbGaP). GTEx subcutaneous adipose tissue sam-
ples were obtained from the lower legs of post-mortem donors. To
ensure comparability, GTEx data were re-aligned and quantified
with the same pipeline used by TwinsUK. In addition, gene-
expression principal-component analysis (PCA) outliers were
removed; outliers were defined by use of k-means clustering
(k ¼ 2) fit to the first two expression principal components
(PCs). 326 QC’d samples were retained for analysis and are listed
with their cell-type proportions in Table S2.1014 The American Journal of Human Genetics 104, 1013–1024, JunReference Cell-Type Data
To create the adipose signature matrix, we utilized reference RNA-
seq datasets for each cell type selected from publicly available
RNA-seq data from either primary (CD4þ T cells, HMVEC),
PSC-derived (adipocytes), or iPSC-derived (macrophages) sources.
Reference RNA-seq data were obtained from the Sequence Read
Archive (SRA) as raw FASTA files. All datasets are listed in
Table S3. One independent set of experiments was used for con-
struction of the adipose tissue signature matrix, and another in-
dependent set was used for construction of in silico simulated
mixtures for testing deconvolution accuracy. To ensure compara-
bility, we aligned reference cell-type data and quantified them by
using the same pipeline used for bulk tissue. We were prevented
from estimating additional cell types by the unavailability of
reference datasets for those cell types at the time of study, a
lack of replicates that would ensure stable construction of the
signature matrix, or very low frequency in the tissue (e.g., mast
cells). Biological replicates of each of the four reference cell types
were included.
Construction of CIBERSORT Adipose Signature Matrix
RNA-seq data obtained from cell types and their biological repli-
cates were constructed into a reference cell-type matrix with n
rows (genes) and m columns (cell types). We also constructed a
class file to describe the pairwise comparisons that one must
perform between cell types in order to produce the signature ma-
trix.21 The signature matrix contains all genes differentially ex-
pressed between the cell types at a specified false discovery rate
(FDR) (q ¼ 0.30, default). The CIBERSORT analytical tool has the
additional benefit that each tissue or mixture is deconvolved
with potentially different signature genes. This is due to the algo-
rithm’s implementation of a n–support vector regression (n-SVR)
step in which only the maximally separating support vectors are
retained for the linear regression. n-SVR also aids in minimizing
co-linearity as measured through the matrix condition number
(k), an ideal step during estimation of cell types that are biologi-
cally closely related.
Estimating Cell Types from Bulk Adipose-Tissue RNA-
Seq Data
CIBERSORT was used for estimation of cell-type proportions from
adipose-tissue RNA-seq samples from both TwinsUK and GTEx.21
For signature matrix construction in CIBERSORT, we used the
default value of q¼ 0.30 for the FDR because CIBERSORT’s support
vector regression procedure ensures that a subset of genes that
maximally separate cell types is present in each individual adipose
tissue sample, so it is therefore better to have a lower-false negative
rate when detecting the initial set of signature genes. CIBERSORT
also reports the condition number (k) of the signature matrix, a
measure of co-linearity and matrix stability. The signature matrix
has a low kappa (k¼ 3.22), suggesting that a well-conditionedma-
trix was achieved. CIBERSORT provides a deconvolution p value
per sample, calculated from 1,000 bootstrapped permutations.21
We required a deconvolution p value < 0.01 corresponding to
an FDR of 1%.
In Silico Mixture Simulations
Reference cell types were combined in random proportions to
generate 1,000 in silico simulated cell mixtures, termed ‘‘the
ground truth’’ (S). We generated a mixture matrix (M) by drawing
variables (equal to the total number of cells to form a mixturee 6, 2019
with) from a random uniform distribution normalized to sum to
one and multiplied by the reference cell matrix (C):
S ¼ CMT
S ¼ truth (known simulated proportions)
C ¼ matrix of reference cell expression profiles
M ¼ mixture matrix specifying amount of each cell type [0–1]
A natural amount of noise is introduced into this problem
because the reference cell types are obtained from different labora-
tories that use different sequencing chemistries. This is ideal
because the same problem is present for the deconvolution of
the real adipose-tissue mixtures, making the simulated data
more realistic. However, to make the problem more challenging
and to assess the signature matrix’s limit and ability to deal with
noise in mixture profiles, we added 10% to 100% scaled randomly
distributed Gaussian noise to each simulated sample:
y1 ¼y0 þ X þ y0 S
x ¼ random normal variable with X N (0, 1)
y0 ¼ simulated in silico mixture
y1 ¼ simulated in silico mixture with added noise
S ¼ scale factor [0–1]
GTEx Histology Images and Pathologist Notes
Histological images of GTEx biopsies along with accompanying
pathologist notes were obtained from the GTEx web portal.
Although the GTEx histology slides were prepared from a piece
of material adjacent to the piece utilized for RNA-seq, they are
reflective of the overall tissue sample taken.
Association between Cell-Type Composition and GTEx
Covariates
To assess the relationship betweenGTEx adipose tissue cell propor-
tion estimates and ischemic time, we fit a linear model controlling
for age, sex, BMI, and batch against each cell type estimated. Addi-
tionally, we performed PCA on the cell-type proportion matrix
and assessed whether ischemic time was correlated to any one of
the first three PCs. Finally, given that GTEx is composed of both
male- and female-derived samples, we tested for any presence of
sexual dimorphism for each cell type while controlling for BMI,
age, ischemic time, and batch.
Heritability Estimation
Heritability calculations were performed with OpenMx.22 We fit a
standard additive genetic variance, common environmental fac-
tors, and nonshared environment model in which additive ge-
netic, common, and unique environment-variance components
were estimated formacrophage and adipocyte proportion between
twin pairs.
Association between Cell-Type Composition andWhole-
Body Phenotypes
Association between cell-type proportion and whole-body pheno-
types (BMI, body-fat distribution, and age) were conducted in the
TwinsUK datasets under linear models (lm) in R. All phenotypes
were collected at the time of biopsy. Body-fat distribution mea-
surements of android, gynoid, and visceral fat volume were
quantified (n ¼ 652) via dual-energy X-ray absorptiometry
(DXA; Hologic QDR 4500 plus) according to the standard manu-
facturer’s protocol.The AmericaAssociation between BMI and Gene Expression
Each gene-expression measurement (TMM) was tested as a depen-
dent variable in a linear mixed-effects model that accounted for
family structure as previously described in detail.20 Independent
variables in addition to BMI and macrophage proportion included
technical covariates that are well known to have strong effects
on RNA-seq gene expression studies (fixed effects: insert-size
mode, mean GC content, primer index) (random effects: date
of sequencing). Using a single-degree-of-freedom ANOVA, we
compared the model fit, which was adjusted for macrophage
proportion with the null model but was not adjusted for
macrophages.
Weighted Gene Co-Expression Network Analysis
Signed weighted gene co-expression network analysis (WGCNA)
was carried out with WCGNA version 1.62 in R as previously
described.23 Gene networks have been shown to follow a scale-
free topology. WGCNA uses soft thresholding to find modules of
highly correlated co-expressed genes. The overall process has
been described previously.
cis-eQTL Analysis
For global cis-eQTL analysis, each cis-window was defined as a
1 MB region around the transcription start site (TSS) of each
gene. SNPs with an MAF R 5% were analyzed. We used eigenMT
to determine significant associations.24 eigenMT calculates the
number of effective tests per cis-window by performing eigenvalue
decomposition and taking the effective number of tests as equal
to the eigenvalues that explain 99% of the variance. This proced-
ure has been shown empirically to control the FDR similarly to
permutations. All analysis was performed with inverse-rank-
normalized gene-expression residuals corrected for experimental
covariates.20 All analysis was conducted with the MatrixeQTL
package.25 We obtained probabilistic estimation of expression
residuals (PEER)-corrected residuals by correcting for 30 PEER
factors.26
Gene-by-Cell Proportion Interaction Modeling
Interaction models were fitted with the ‘‘modellinear cross’’
function in MatrixQTL.25 To maximize the power to detect
cis-eQTLs that are dependent on cell-type proportion, we in-
ferred 30 PEER factors by using inverse-rank normalized gene
expression residuals corrected for sequencing date, zygosity,
and family structure. Interaction models for relative macrophage
proportion were adjusted for the following covariates: 30 PEER
factors, mean GC content, insert size, BMI, and age. We also in-
verse normalized macrophage proportion to ensure normally
distributed errors.Results
Accurate Cell-Type Estimates That Are Robust against
Unknown Content and Noise
We estimated cell-type proportion in bulk adipose tissue
RNA-seq profiles with CIBERSORT, a n-support vector
regression (n-SVR) method that estimates cell proportions
by using gene expression obtained from solid tissues.21
CIBERSORT identifies cell-type-specific marker genes
from reference cell transcriptome profiles to construct a
tissue-specific signature matrix, a set of differentiallyn Journal of Human Genetics 104, 1013–1024, June 6, 2019 1015
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Figure 1. Cell-Type Proportion Is Accu-
rately Estimated in In Silico Mixture
Simulations
Each panel displays cell-type estimation in
1,000 in silico mixtures. Each point repre-
sents one simulation.expressed genes across all cell types, and utilizes this signa-
ture matrix to perform the deconvolution step.
To construct theCIBERSORTadipose-tissue signaturema-
trix, we obtained previously published RNA-seq datasets
from reference in vitro cells, including both primary cells
and iPSC-derived cells that are known to be present in sub-
cutaneous adipose tissue; these include adipocytes, macro-
phages, CD4þ T cells, and microvascular endothelial cells
(MVECs) (Table S3). Adipose tissue is comprised of many
more cell types than the four we focus on here. Hierarchical
clustering of the reference transcriptional profiles recapitu-
lated developmental cellular hierarchy (Figure S1). Thefinal
CIBERSORT adipose signature matrix is comprised of 658
genes, including several encoding well-known cell-type-
specific markers. Examples include SCD (MIM: 604031),
COL1A1 (MIM:120150), andADIPOQ (MIM:612556) in ad-
ipocytes; SERPINE1 (MIM: 173360),MMP1 (MIM: 120353),
and VWF (MIM: 613160) in endothelial cells; SPP1 (MIM:
166490), F13A1 (MIM: 134570), and CTSC (MIM: 602365)
in macrophages; and FOS (MIM: 164810), TCF7 (MIM:
189908), and CD3 (MIM: 186780) in T cells. The full signa-
ture matrix is included in Table S4.
To test deconvolution ability, accuracy, and robustness to
noise, we performed several simulations that are typically
used for benchmarking deconvolution accuracy.19,21 First,
we tested whether the adipose tissue signature matrix can
accurately identify the four cell types when applied to a
set of independent reference cell-type RNA-seq datasets.1016 The American Journal of Human Genetics 104, 1013–1024, June 6, 2019All benchmark cell types were esti-
mated with high accuracy: three out
of four cell types attainedR 99% accu-
racy in prediction (Table S5). Macro-
phages (93% accuracy) are particularly
difficult to purify, so it is possible that
the 6% CD4þ T cells we estimate in
the macrophage benchmark sample
were present in the original reference
macrophage sample.
We next assessed the ability to esti-
mate the constituent cell proportions
of a mixture of known cell types. We
created 1,000 in silico mixtures of
known proportions of each of
the four cell types with the indepen-
dent reference cell-type datasets
(Table S3). Application of CIBERSORT
to the in silicomixtures yielded highly
accurate estimates of cell-type propor-
tion; values for the mean absolute de-viation (mAD) of estimated proportions to ground truth
ranged from 0.019 to 0.068 (Figure 1). Biopsies can contain
contaminant cells from other tissues, which could inflate
cell-type proportion estimates if contaminant cells share
marker genes with any of the four cell types we are esti-
mating. To test this, we added proportions of smooth-mus-
cle cells, dendritic cells, and neutrophils to the in silico
mixtures of the four cell types. These cell types can be pre-
sent in adipose tissue and therefore reflect realistic
‘‘contaminant cells.’’ Neutrophils make up 60%–70% of
whole blood and are a likely contaminant. Cell-type pre-
diction was accurate when up to 10% of a sample was
composed of contaminant cell types (Figure S2). We note
that adipose-resident cells not included in our matrix but
with similar expression profiles to that of a reference cell
could inflate estimates of that cell type; in particular, the
estimated adipocyte proportion might be inflated because
of the lack of appropriate reference RNA-seq for adipocyte
mesenchymal stem cells and pre-adipocytes. It is likely
that the content of unknown cells in the samples is %
10% given previously published cell-type estimates from
adipose tissue,;27,28 thus, the adipose tissue signature ma-
trix is robust in estimating cell types from mixtures with
some unknown content.
Technical factors during library preparation and
sequencing introduce noise in RNA-seq experiments.
Therefore, as in previous work, we tested how much
noise we could introduce into the simulations and still
Figure 2. Distribution of Relative Cell-
Type Estimates in TwinsUK and GTEx
Adipose Samples
TwinsUK samples are shown on the left,
and GTEx samples are on the right.accurately predict cell-type proportions.21 We added 10%,
50%, and 90% Gaussian noise, in addition to the naturally
occurring noise present in each of the separate experimen-
tally derived reference RNA-seq datasets. The estimates are
robust when up to 10% of the mixture is distorted with
noise, and a linear relationship between ground truth
and predicted estimates still holds when large amounts
of noise are introduced (Figure S3).
Estimation of Relative Cell-Type Proportions in Bulk
Adipose RNA-Seq Datasets
We applied CIBERSORT and the adipose-tissue signature
matrix to a previously published dataset of 766 subcutane-
ous adipose-tissue biopsies obtained from female twin par-
ticipants in TwinsUK.5,6 All 766 TwinsUK RNA-seq samples
were successfully deconvolved at an FDR of 1%. Adipocytes
were the most dominant relative cell type (0.73–0.99), but
also showed significant inter-subject variability (Figure 2).
Proportions of the other estimated cell types ranged from
0.004–0.22 for macrophages (M1 and M2 combined),
0–0.19 for MVEC, and 0– 0.11 for CD4þ T cells (Figure 2).
These estimates agree with previously published studies us-
ing flow cytometry (Table S6). Because the vast majority of
TwinsUK adipose samples had CD4þ Tcell estimates below
1%, we chose to focus on adipocyte, macrophage, and
endothelial-cell estimates for downstream analysis. How-
ever, we investigated whether there were any distinct
differences between individuals who had non-zero CD4þThe American Journal of Human GeT cell counts. In total, two individuals
had CD4þ proportions >5%, and 24
individuals had CD4þ proportions
>1%. Neither BMI nor age differed
significantly between these subjects:
BMI (BMIlow CD4þ 26.6, BMIhi CD4þ
26.7) and age (Agelow CD4þ 59.4,
Agehi CD4þ: 60.9).
We next applied CIBERSORT to an
independent sample of 326 post-mor-
tem subcutaneous adipose tissue bi-
opsies from the GTEx. In contrast to
the samples from TwinsUK, 23% of
GTEx samples (75/326) failed success-
ful deconvolution (1% FDR), suggest-
ing substantial differences in cell
types present in the tissue from the
signature matrix. As compared to the
TwinsUK samples, the 251 GTEx sam-
ples that passed deconvolution had
markedly different cell-type composi-
tion profiles, including a lower adipo-cyte fraction (GTExmedian ¼ 0.62, TwinsUKmedian ¼ 0.82),
twice as much vasculature (GTEx median MVEC propor-
tion¼ 0.30, TwinsUK¼ 0.15), and four times asmanymac-
rophages (GTEx median macrophage ¼ 0.08, TwinsUK ¼
0.02) (Figure 2). Overall, all cell types between GTEx and
TwinsUK differed significantly (adipocytes—t statistic ¼
39.78, p value ¼ 7.77 3 10211; macrophages—t
statistic ¼ 22.585, p value ¼ 4.89 3 1092; MVEC—t
statistic ¼ 32.02, p value ¼ 5.75 3 10157).
To assess the GTEx estimates, we investigated whether
there were visible histological differences between samples
with differential macrophage proportion estimates in
GTEx adipose histology slides. We observed concordance
between our estimates and visual inspection of the histol-
ogy slides. We demonstrate this in Figure 3, where the sam-
ple with the lowest macrophage proportion (estimated at
0%) is composed primarily of adipocytes with few addi-
tional cells present. In stark contrast, the sample with the
highest macrophage proportion (estimated at 49%) has
substantial vasculature and blood cells present.
Tovalidate thedifference inadipocyteproportionbetween
thedatasets,we focusedontheexpressionofADIPOQ,which
encodes the hormone adiponectin. ADIPOQ is expressed
highly in adipocytes and pre-adipocytes.29 ADIPOQ was ex-
pressed 4-fold higher in the TwinsUK dataset (median
TMM ¼ 3998, expression rank ¼ 19) compared to the
GTEx dataset (median TMM ¼ 963, expression rank ¼ 59).
The distribution and range of ADIPOQ expression variednetics 104, 1013–1024, June 6, 2019 1017
Figure 3. Estimated Cell-Type Composition of GTEx Samples
Corresponds to Image Data
Histology images from the GTEx adipose samples with the highest
(49%) (top) and lowest (0%) (bottom) macrophage estimates are
shown. Both whole-biopsy (left) and zoomed-in images (right)
are presented. Estimated cell-type composition of all GTEx sam-
ples is provided in Table S2.between thedatasets; it followedanormaldistribution in the
TwinsUKdataset (untransformed, TMMdata) andwasheavi-
ly skewed to the right in the GTEx dataset (Figure S4).
ADIPOQ expression is very low in some GTEx samples as
compared to TwinsUK, which suggests fewer viable
adipocytes (GTEx ADIPOQmin ¼ 3.13 TMM; TwinsUK
ADIPOQmin¼986TMM)(FigureS4).TheADIPOQ results sup-
port theCIBERSORTestimatesof loweradipocyteproportion
in the GTEx samples.
There are several possible additional explanations of
why cell-type proportions differ between the TwinsUK
and GTEx datasets. The function and metabolic activity
of adipose tissue is known to vary between fat depots—
markedly between android (above the hip) and gynoid
(below the hip) depots. The GTEx adipose samples were
obtained via surgical incision from the lower left leg (gy-
noid fat depot), whereas the TwinsUK samples were
derived from punch biopsies from the abdomen (android
fat depot). Additional fibrosis is likely to alter the number
of viable cells available for sequencing in post-mortem
samples; GTEx pathologist notes frequently recorded the
presence of large fibrotic regions (up to 60% of a given his-
tology slide). In the GTEX data, ischemic time was not
associated with any individual cell type but was
correlated with the overall cellular heterogeneity of a sam-
ple (p value ¼ 0.0085, r ¼ 0.15), indicating that differences
in cell estimates among GTEx samples are partially due to
variability in ischemic time between samples. We also note
that sex was associated with both adipocytes (p value ¼
0.028) and MVEC (p value ¼ 0.019) proportion in the1018 The American Journal of Human Genetics 104, 1013–1024, JunGTEx dataset, whereas the TwinsUK population was all fe-
male. Given the large disparities in estimated cell composi-
tion between the datasets, we chose to focus on the
TwinsUK dataset for the following analysis.
Adipose Cell-Type Proportions Are Heritable
Several studies have demonstrated that the cell-type
composition of whole blood is heritable, but the influence
of genetics on adipose cell-type composition has not been
explored.30,31 Using structural equation models, we esti-
mate the narrow-sense heritability (h2) of adipocyte,
macrophage, and endothelial cell proportion to be 17%,
30%, and 21% respectively in the TwinsUK data. The her-
itability of adipose tissue cell composition might be medi-
ated by genetic drivers of whole-body traits, such as BMI,
that in turn drive changes in cell-type proportion or might
be mediated by local effects within adipose tissue—effects
such as rates of adipogenesis or angiogenesis.
Adipose Tissue Cell-Type Proportion Is Associated with
Whole-Body Obesity Traits but Not Age
Macrophage infiltration and abundance in adipose tissue is
known to increase with obesity and its associated chronic
inflammation.32 Recapitulating this finding, we demon-
strate a significant correlation between BMI and estimated
adipose macrophage proportion in the TwinsUK data
(Table 1). To explore the relationship between cell-type
compositionandbody-fat distribution,weusedhighly accu-
rate dual X-ray absorptiometry (DXA) measures of visceral
fat volume (VFAT) and android/gynoid (A/G) ratio in a sub-
set of twins (n ¼ 652) with concurrently measured DXA
scans. Despite the smaller sample size, the correlation coeffi-
cients between the A/G ratio and visceral fat with relative
macrophage estimateswere significantly larger than the cor-
relationofBMIwith relativemacrophageestimates (Table1).
IncludingBMI as a covariate did not change the associations
to DXA-derived traits, indicating that body-fat distribution
is associated with adipose tissue cell composition indepen-
dent of overall adiposity. This finding confirms the impor-
tance of macrophage biology in obesity but also suggests
that inflammation plays a more prominent role in body-
fat distribution than is currently appreciated.
In contrast to the well-documented association between
whole-blood cell-type composition and age, there was no
association between age and either macrophage or adipo-
cyte proportion (r ¼ 0.02).13 This indicates that adipose
cell-type composition is not a major confounder in identi-
fication of age-related transcripts,33 nor is it differentially
methylated in adipose tissue.34
Adjusting for Macrophage Heterogeneity Accounts for
11% of Genes Displaying BMI-Related Differential
Expression
BMIhasaprofoundeffectonadipose tissuegeneexpression;
themajority of the adipose transcriptome is associatedwith
BMI in studies conducted with both microarrays and
RNA-seq in independent populations.7,9,20 It is uncleare 6, 2019
Figure 4. Adjusting for Macrophage Proportion Accounts for
11% of Associations between Gene Expression and BMI
Each point represents one gene and is colored as follows: red –
significant in neither association; light blue – significant in
macrophage-adjusted association only; dark blue – significant in
unadjusted association only; and green – significant in both
associations.how many BMI-associated changes in gene expression are
mediated by the changes in cell-type composition that
accompany increasingBMI.Toaddress this,we identifiedas-
sociations between gene expression and BMI under two
models, one model adjusting and one not adjusting for
macrophage proportion. In the first model, we recapitulate
previous results with expression of 6,366/14,897 protein-
coding genes significantly associated with BMI (Bonfer-
roni-corrected p ¼ 3.56 3 106). When we adjusted for
macrophageproportion,11%ofassociationswereno longer
significant (Figure 4). This demonstrates that although
inflammation is an important aspect of obesity etiology,
themajority (89%) of BMI-expression associations are likely
to be independent of macrophage proportion. An example
of one of the 707 genes that are no longer significant after
adjustment for macrophage proportion is CD209 [MIM:
604672] poriginal ¼ 7.72 3 108, padj ¼ 0.0019), a gene that
encodes for a C-type lectin that is found primarily on the
surfaces of macrophages and dendritic cells. Additional
example genes that were no longer significant include
LILRA2 [MIM: 604812], MNDA [MIM: 159553], and
CMKLR1 [MIM: 602351] which are known to be primarily
expressed in macrophage and immune cell lineages.35,36Cell-Type Proportion Explains Major Components of
Gene Expression Variance and Co-Variance
Principle component analysis (PCA) is commonly used to
understand the sources of gene expression variance. We
identified principle components in the TwinsUK samplesThe Americaand correlated them to cell-type proportion estimates.
PC1 was correlated with adipocyte and endothelial cell
proportion (R ¼ 0.40, p value % 2.2 3 1016; R ¼ 0.41,
p value ¼ 2.2 3 1016, respectively). PC2 was negatively
correlated with macrophage proportion (R ¼ 0.63,
p value % 2.2 3 1016) and positively correlated with
endothelial cell proportion (R ¼ 0.21, p value % 3.7 3
109). PC1 and PC2 cumulatively explained 25% of adi-
pose tissue gene expression variance (Figure S5). This indi-
cates that cell-type heterogeneity at the population level is
a major driver of gene expression variation in adipose tis-
sue, and accounting for principle components in down-
stream analysis should account for some of this variability.
Weighted gene co-expression network analysis (WGCNA)
is a widely used technique that uses the correlation structure
of global gene expression profiles to construct modules of
genes, some of which have been ascribed distinct functional
roles or correspond to gene networks. 11 out of 13WCGNA
modules in the TwinsUK data correlated with cell-type pro-
portion (Figure S6, p.< 0.0038). Themost significantmacro-
phage-proportion-associated module (Pearson’s R ¼ 0.67,
p value% 2.23 1016) (Figure S6A) recapitulated themacro-
phage-enriched metabolic network (MEMN), an adipose
gene expression signature associated with increasing
BMI.7,37 The MEMN-green module’s constituent genes
were enriched for glycoproteins (p value¼ 7.13 1063), im-
munity (p value ¼ 1.1 3 1023), and the innate immune
response (pvalue¼4.531012). Endothelial-cell proportion
was positively correlated with the turquoise module
(r ¼ 0.41), which was significantly enriched for GO terms
related to angiogenesis (p value ¼ 6.4 3 1012). These find-
ingsdemonstrate that cell-type composition is amajor driver
of co-expression in bulk-tissue RNA-seq samples and could
confound analysis if samples are not matched for cell-type
proportion.
Correction for Macrophage Heterogeneity in Adipose
Tissue Increases Cis-eQTL Discovery Yield
To determine whether adipose cell-type heterogeneity can
confound cis-eQTL analysis, we investigated the effect of
correcting for cell type in cis-eQTL analysis. We imple-
mented a naı¨ve cis-eQTL discovery model (we did not
adjust for any cell-type proportion) and a separate, macro-
phage-corrected eQTL model. Adjusting for macrophage
heterogeneity among samples led to a modest increase in
cis-eQTL yield (2.3%) (naive model ¼ 5,531, macrophage-
adjusted model ¼ 5,665 SNP-gene pairs, FDR5%). However,
it has become standard practice in cis-eQTL studies to use
gene expression principle components, PEER factors, or
other factor-analysis-based methods to estimate and adjust
out confounding factors from gene-expression data. To test
whether latent factors account for cell-type proportion vari-
ability, we re-ran the naive and cell-type-adjusted cis-eQTL
scans and included adjustment for 30 PEER factors. PEER-
factor adjustment achieved a similar increase in cis-eQTL
yield in the naive and cell-type-adjusted models and re-
sulted in near identical results (naı¨ve PEER ¼ 7,665,n Journal of Human Genetics 104, 1013–1024, June 6, 2019 1019
Table 1. TwinsUK Macrophage Proportion in Adipose Tissue Is
Associated to Obesity-Related Traits but Not Age Suggested edited
table:
Trait r2 p Value
Macrophage
BMI 0.22 2.2 3 108
visceral fat 0.29 4.9 3 1015
visceral fat (BMI adjusted) 0.28 1.9 3 109
android/gynoid ratio 0.36 1.2 3 1016
android/gynoid ratio (BMI adjusted) 0.35 1.8 3 1012
age 0.02 n.s
Adipocyte
BMI 0.15 5.7 3 105
visceral fat 0.13 3.4 3 104
visceral fat (BMI adjusted) 0.07 0.05
android/gynoid ratio 0.16 2.7 3 105
android/gynoid ratio (BMI adjusted) 0.11 0.002
age 0.004 n.s
MVEC
BMI 0.21 3.62 3 109
visceral fat 0.23 6.2 3 1010
visceral fat (BMI adjusted) 0.14 1 3 104
android/gynoid ratio 0.26 6.5 3 1013
android/gynoid ratio (BMI adjusted) 0.20 1.1 3 107
age 0.006 n.s
BMI: body mass indexmacrophage-adjusted PEER ¼ 7,664). This confirms that
latent factors capture the cell-type composition differences
among adipose samples, as well as many other unmeasured
latent factors, but if covariates are known, it is better to
adjust with a fully specified model than to estimate latent
factors given the known risk of collider bias.38
Identification of Cell-Type-Specific eQTLs from Bulk
Tissue
Previous studies have identified cell-type-specific eQTLs in
bulk whole-blood expression profiles by fitting gene
expression to cell-type interaction models.39 We utilized
this strategy to detect cell-type-specific cis-eQTLs in the
TwinsUK adipose data. At a strict Bonferroni-corrected
threshold (p value threshold ¼ 1.01 3 109, based on
49,219,795 association tests in the 1-MB TSS-centered win-
dow around 14,897 genes), we identified 26 G 3 cell-type
interactions at 20 unique genes (Table 2) (Figure S7).
Twelve gene-SNP pairs had an interaction with macro-
phage proportion, 10 with endothelial proportion, and
four with adipocyte proportion (Table 2). Examples
include MARCO [MIM: 604870], encoding a macrophage
receptor that has collagenous structure and whose expres-
sion depends on macrophage proportion, and rs1884841.1020 The American Journal of Human Genetics 104, 1013–1024, JunTC2N, which is responsible for the secretion of VWF
from endothelial cells, and DEFB1 [MIM: 602056] both
showed a positive interaction with adipocytes and a nega-
tive interaction with endothelial cells.
Five macrophage-dependent eQTLs were replicated in a
context-specific monocyte eQTL dataset.41 Four of the five
were detected in an IFN-g- or LPS-challenged state. Overall,
the lead G 3 cell-type-proportion SNPs were enriched for
overlap with HaploReg enhancer annotations in primary
monocytes (p value ¼ 0.001) and neutrophils (p value ¼
0.004), consistent with the large number of G 3 cell eQTLs
dependent on macrophage proportion (60%).
We intersected all 26 significant G 3 cell interactions
with genome-wide significant (GWS) associations in the
NHGRI GWAS catalog and identified nine G 3 cell lead
SNPs that overlap with GWAS variants or are in strong link-
age disequilibrium (LD) (r2> 0.80, D’> 0.9) with GWS loci.
Seven out of nine of these SNPs are within the MHC and
are coincident with multiple immune- and autoimmune-
disorder GWAS loci. The seven G 3 cell interaction SNPs
in the MHC appear to represent independent signals, and
only two (rs28383362 and rs28383372, r2 ¼ 0.66) showed
a pairwise r2 greater than 0.51. TwoMHC genes,HLA-DRB5
[MIM: 604776] and HLA-DBQ1 [MIM: 604305], had inter-
actions with both the endothelial and the macrophage
proportion at two different SNPs that are not in LD
(HLA-DRB5-rs9270111 and rs28383362 r2 ¼ 0.1; HLA-
DBQ1-rs1063347 and rs3819715 r2 ¼ 0.003), indicating
that different SNPs regulate these genes in the different
cell types. The two non-MHC GWAS coincident G 3 cell
interaction SNPs are rs1351111, which is coincident with
GWAS lead SNPs for Behcets disease (r2 ¼ 1; rs2617170)
and whose regulation of KLRK1 [MIM: 611817] is depen-
dent on macrophage proportion,42 and rs4728142, whose
regulation of IRF5 [MIM: 607218] is dependent on endo-
thelial proportion and which is the lead SNP in GWASs
for a range of auto-immune diseases including ulcerative
colitis and systemic lupus erythematous.43,44
Cell Types Are Not Associated with BMI Genetic-Risk
Scores
To understand whether adipose cell-type variability was
due to the genetic control of BMI, we sought to determine
whether any of our cell proportion estimates were
associated with BMI genetic-risk scores (GRSs). First, we
calculated weighted BMI GRSs on the full set of
TwinsUK-genotyped individuals. For the GRS calculations,
we used the 941 BMI SNPs reported in the latest BMI GWAS
meta-analysis.45 Of these, 926 were present in our QC-ed
imputation. Betas and effect alleles were extracted from
meta-analysis summary statistics. We note that the GRS
are positively associated with median BMI (median of all
longitudinal measurements) in the full TwinsUK sample
(beta ¼ 3.6; p value ¼ < 2.23 1016. R2 for median BMI re-
siduals adjusted for all other covariatesz1.7%, n¼ 6K). To
assess whether BMI GRS is associated with macrophage
infiltration or in fact any cell type estimated in thesee 6, 2019
Table 2. G 3 Cell-Proportion Interactions Identify Cell-Type-Specific eQTLs from Bulk Adipose-Tissue Gene-Expression Profiles
Cell Type SNP Gene b p Value
Fairfax et al.
Stimulus &
Proxy SNP GTEx Top eQTL Tissues Regulatory Regions
macrophage rs61913538 CLEC12A 0.37 8.4 3 1025 naive, rs7313235 WB, adipose, muscle blood promoter
macrophage rs1063355 HLA-DQA1 0.29 3.0 3 1018 NA WB, skin, muscle blood promoter. breast/
skin DNAase
macrophage rs1351111 KLRC4-KLRK1 0.34 4.6 3 1015 NA NA blood þ skin promoter
macrophage rs1351111 KLRK1 0.35 1.5 3 1014 NA adipose, fibroblast, muscle blood þ skin promoter
macrophage rs2422631 SIRPB1 0.40 2.2 3 1013 NA WB, lung, nerve blood DNAase
macrophage rs28383372 HLA-DQA2 0.25 2.2 3 1013 NA WB, lung, adipose 5þ-tissue promotor
macrophage rs866865 KCNMA1 0.30 3.7 3 1013 IFN-g, rs752372 WB, adipose, lung blood enhancer
macrophage rs2278589 MARCO 0.40 1.8 3 1012 NA adipose, WB, skin adipocytes, monocytes
macrophage rs1063347 HLA-DQB1 0.29 7.9 3 1012 NA WB, lung, skin blood promoter þ histone
marks
macrophage rs634512 LYZ 0.27 2.2 3 1011 LPS24, rs1384 WB, lung, artery blood promoter. breast/skin
DNAase
macrophage rs4528348 MS4A14 0.26 5.4 3 1011 LPS24, rs2233253 adipose, lung, nerve blood promoter þ enhancer
liver/lung enhancer þ DNAase
macrophage rs2327276 VNN2 0.34 7.8 3 1011 IFN-g, rs1883613 adipose, WB, lung blood þ skin promoter
endothelial rs28383362 HLA-DQA2 0.34 1.5 3 1022 NA WB, muscle, adipose blood promoter þ enhancer
endothelial rs1884841 TC2N 0.23 1.0 3 1012 NA nerve, adipose, artery blood DNAse þ enhancer
endothelial rs182366 B3GALNT2 0.26 7.0 3 1012 NA nerve, adipose, thyroid blood promoter, skin DNAase
endothelial rs2744944 UHRF1BP1 0.26 8.16 3 1012 NA artery, muscle, fibroblast blood enhancer
endothelial rs2977786 DEFB1 0.27 4.3 3 1011 NA adipose, heart, nerve 5-þ tissue promotor
endothelial rs61799378 SLC25A24 0.28 1.5 3 1010 NA testis, WB, fibroblast blood promoter
endothelial rs4728142 IRF5 0.28 3.2 3 1010 NA WB, artery, thyroid blood/fat promoter
endothelial rs9270111 HLA-DRB5 0.30 6.3 3 1010 NA muscle, WB, adipose blood cell enhancer
endothelial rs3819715 HLA-DQB1 0.35 9.0 3 1010 NA adipose, muscle, skin blood cell enhancer
endothelial rs3760516 VAMP2 0.33 9.6 3 1010 NA nerve, brain, thyroid blood promoter þ enhancer
adipocyte rs28383362 HLA-DQA2 0.26 4.2 3 1013 NA WB, muscle, adipose blood promoter
adipocyte rs2977786 DEFB1 0.27 4.6 3 1011 NA adipose, heart, nerve blood promoter
adipocyte rs1812350 B3GALNT2 0.25 6.1 3 1011 NA nerve, adipose, thyroid blood promoter
adipocyte rs1884841 TC2N 0.20 6.2 3 1010 NA nerve, adipose, artery heart/muscle promoter
The first column, ‘‘Cell Type,’’ lists the cell-type proportion estimate included in the G 3 cell-proportion interaction model. Macrophage proportion interactions
replicated in Fairfax et al., 201540 have proxy SNPs and stimuli condition annotated. The top three eQTL tissues in GTEx are listed on the basis of effect size.
The ‘‘Regulatory Regions’’ column lists HaploRegv4 annotations at the lead SNP. All promoters, enhancers, and other regulatory annotation enrichments are
derived from HaploRegv4.analyses, we fit linear mixed models accounting for twin
relatedness and age. We find no association between BMI
GRS and cell estimates (all p value > 0.05); this suggests
that cell proportion variation isn’t driven by genetically
influenced obesity, and it is therefore likely to be a second-
ary effect of becoming overweight or obese.Discussion
RNA-seq profiling of bulk-tissue biopsies is widely used for
biomarker discovery, genetics of gene expression studies,The Americaand differential expression analysis5,9,20,40 but the cellular
complexity of primary-tissue biopsies is often unaccounted
for. In this study, we used in silico methods to characterize
the variability of adipose cell-type composition in two large
bulk-tissue transcriptomic datasets and explored the effects
of adipose cellular heterogeneity on a range of transcrip-
tomic analyses. Our results indicate that it is critical to ac-
count for cell-type composition when combining adipose
transcriptome datasets in co-expression analysis and in dif-
ferential expression analysis with obesity-related traits.
Although the ability to detect interactions with esti-
mated cell proportions is limited in terms of both samplen Journal of Human Genetics 104, 1013–1024, June 6, 2019 1021
size and the accuracy of cell-type estimation from a com-
plex tissue such as adipose, we have demonstrated that
its possible to detect cell-type-proportion-dependent
eQTLs in whole adipose tissues. We identified 26 macro-
phage-, endothelial-, or adipocyte-specific eQTLs within
our bulk adipose tissue RNA-seq datasets, and we note
that all of these hadmain-effect eQTLs in TwinsUK adipose
tissue and in several GTEx tissues (Table 2). The presence of
immune- and endothelial-specific eQTLs is expected in
other tissues with resident immune cells and blood vessels,
however, three of the four adipocyte-dependent eQTLs
have been found to be eQTLs in GTEx nerve tissue. Adi-
pose tissue is spread throughout the body and around or-
gans, and obtaining adipose-free biopsies of many tissues,
including nerve, thyroid, and muscle tissues, is technically
difficult, as is clearly documented in the GTEx pathologist
notes and histology slides that are provided for every
biopsy. Our conjecture is that the presence of adipocyte-
specific eQTLs in nerve tissue is a result of adipose contam-
ination of the nerve biopsies. This suggests that estimates
of tissue sharing of expression or regulatory effects be-
tween adipose and some tissues are likely to be an overes-
timated.46 It is thus important to consider the cell-type
composition of biopsies prior to utilizing expression or
eQTL data to interpret disease loci, and in particular
before prioritizing a tissue or cell type for downstream
experiments.
Several shortcomings of our study are worth mentioning
for future improvements. We have estimated the relative
proportion of cell types in two biopsy datasets, and it is
important to note that the content of a biopsy might not
be representative of the cell content of the in vivo tissue
from which it was extracted. Many technical factors,
includingmethod of retrieval (surgical biopsy versus lipoas-
piration versus needle biopsy) and sample handling (as
demonstrated by the association between cell-type hetero-
geneity and ischemic time inGTEx), are known to influence
adipose biopsy composition. Second, CIBERSORTestimates
relative fractionsof cell types, not absoluteproportions. This
means the cell-type proportion estimates are only interpret-
able relative to what is included in the signaturematrix and
should not be interpreted as absolute proportions of those
cell types in vivo. Finally, a broader and better-defined signa-
ture matrix would increase both accuracy and utility of the
method. We did not include additional adipose-resident
cell types such as adipose mesenchymal stem cells, pre-adi-
pocytes, and a wider range of lymphocytes due to the lack
of suitable available reference RNA-seq datasets. In partic-
ular, the lack of reference adipose mesenchymal stem cells
andpre-adipocytes could inflate our estimates of the propor-
tion of adipocytes (the cell typemost closely correlatedwith
these cell types) relative to the other cell types in thematrix.
We expect the utility of deconvolution of bulk-tissue gene
expression to further improve as more RNA-seq datasets of
primary and purified cells become available.
We have shown in silico deconvolution to have strong
utility for understanding how cell-type proportions vary1022 The American Journal of Human Genetics 104, 1013–1024, Junin population studies of adipose tissue. We demonstrate
that adipose-cell composition is heritable and associated
with body-fat distribution. Although some of this herita-
bility might be mediated by overall BMI heritability, which
in turn might drive changes in cell composition, it is
possible that certain genotypes could predispose individ-
uals to or protect them from macrophage infiltration and
thereby the consequences of inflammation in obesity. Her-
itable variability in adipocyte number could also underlie
differential capacity for adipose-tissue expansion and stor-
age, which can drive ectopic fat deposition and subsequent
susceptibility to downstream cardio-metabolic disease. The
role of cellular heterogeneity in modulating human health
and disease is a growing area of interest,12 and further
deconvolution of bulk RNA-seq datasets, aided by the ex-
panding availability of RNA from primary and iPSC-
derived cell populations and single-cell analysis, should
contribute to our understanding of how genetics influence
cell-type heterogeneity and its impact on health and
disease.Supplemental Data
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